AI Small‑Cap Sprinter Delivers 43% Return

The AI‑driven Small Cap Sprinters strategy posted a 43.27% total return since launch, beating its benchmark by 38.20 points.
In April, the portfolio highlighted Myriad Genetics (up 8.94%) and Inspire Medical Systems (up 9.09%) after sharp sell‑offs.
Both stocks trade at roughly 34‑40% of their 52‑week highs, with revenue forecasts of $860‑$880 million and $912 million respectively.
The article attributes the upside to conflict‑driven market dislocation and AI’s focus on revenue acceleration, volume spikes, and investor demand signals.